Expression of ARID1A and p53 in Patients With a Consensus Diagnosis of Barrett's Foveolar and Intestinal-Type Dysplasia

被引：0
|
作者：
Willis, Eric [1 ]
Wiland, Homer [1 ]
Allende, Daniela [1 ]
Cruise, Michael [1 ]
Goldblum, John [1 ]
Liu, Xiuli [1 ]
Pai, Rish [1 ]
Plesec, Thomas [1 ]
Yerian, Lisa [1 ]
Carver, Paula [1 ]
Patil, Deepa [1 ]
机构：
[1] Cleveland Clin, Cleveland, OH 44106 USA
来源：
MODERN PATHOLOGY | 2015年 / 28卷
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
790
引用
收藏
页码：198A / 199A
页数：2
相关论文
共 50 条
  • [11] p53 Accumulation Is a Prognostic Factor in Intestinal-Type Gastric Carcinoma but Not in the Diffuse Type
    Franco Roviello
    Daniele Marrelli
    Carla Vindigni
    Alfonso De Stefano
    Donatella Spina
    Enrico Pinto
    Annals of Surgical Oncology, 1999, 6 : 739 - 745
  • [12] p53 accumulation is a prognostic factor in intestinal-type gastric carcinoma but not in the diffuse type
    Roviello, F
    Marrelli, D
    Vindigni, C
    De Stefano, A
    Spina, D
    Pinto, E
    ANNALS OF SURGICAL ONCOLOGY, 1999, 6 (08) : 739 - 745
  • [13] Barrett's dysplasia and the Vienna classification: reproducibility, prediction of progression and impact of consensus reporting and p53 immunohistochemistry
    Kaye, Philip V.
    Haider, Syeda A.
    Ilyas, Mohammed
    James, Peter D.
    Soomro, Irshad
    Faisal, Wasek
    Catton, James
    Parsons, Simon L.
    Ragunath, Krish
    HISTOPATHOLOGY, 2009, 54 (06) : 699 - 712
  • [14] Aberrant p53 Expression Predicts Neoplastic Progression in Barrett's Esophagus Diagnosed as Indefinite for Dysplasia
    Chen, Xiuxu
    Kim, Sun A.
    Paulsen, John
    Ko, Huaibin Mabel
    Zhu, Hongfa
    Polydorides, Alexandros
    Harpaz, Noam
    Liu, Qingqing
    LABORATORY INVESTIGATION, 2020, 100 (SUPPL 1) : 635 - 635
  • [15] Aberrant p53 Expression Predicts Neoplastic Progression in Barrett's Esophagus Diagnosed as Indefinite for Dysplasia
    Chen, Xiuxu
    Kim, Sun A.
    Paulsen, John
    Ko, Huaibin Mabel
    Zhu, Hongfa
    Polydorides, Alexandros
    Harpaz, Noam
    Liu, Qingqing
    MODERN PATHOLOGY, 2020, 33 (SUPPL 2) : 635 - 635
  • [16] P53 Staining as a Marker of Dysplasia Progression Risk in Barrett's Esophagus
    Tomaszewski, Kristen
    Rickelt, Steffen
    Jeck, William
    Taylor, Martin
    Deshpande, Vikram
    Shroff, Stuti
    LABORATORY INVESTIGATION, 2019, 99
  • [17] p53 immunoreactivity in Barrett's metaplasia, dysplasia, and adenocarcinoma - A case report
    Kimura, H
    Konishi, K
    Kaji, M
    Maeda, M
    Yabushita, K
    Miwa, A
    HEPATO-GASTROENTEROLOGY, 2001, 48 (42) : 1662 - 1664
  • [18] P53 Staining as a Marker of Dysplasia Progression Risk in Barrett's Esophagus
    Tomaszewski, Kristen
    Rickelt, Steffen
    Jeck, William
    Taylor, Martin
    Deshpande, Vikram
    Shroff, Stuti
    MODERN PATHOLOGY, 2019, 32
  • [19] Evaluation of P53 immunohistochemistry pattern as a biomarker of dysplasia in Barrett's oesophagus
    Mocanu, D.
    Popp, C.
    Nichita, L.
    Cioplea, M.
    Sticlaru, L.
    Micu, G.
    Vilaia, A.
    Frumosu, M.
    Voiosu, A.
    Ignat, E.
    VIRCHOWS ARCHIV, 2020, 477 : S265 - S265
  • [20] Novel staining pattern of p53 in Barrett's dysplasia - the absent pattern
    Kaye, Philip V.
    Haider, Syeda A.
    James, Peter D.
    Soomro, Irshad
    Catton, James
    Parsons, Simon L.
    Ragunath, Krish
    Ilyas, Mohammad
    HISTOPATHOLOGY, 2010, 57 (06) : 933 - 935
12345